Consultancy at WHO: manage a fund for implementation of AMR-focused actions / 17 Mar 2020 deadline

Dear All,

A fascinating job posting has gone up from WHO and the full text is just below my signature. You have to work your way through the acronyms, but here’s the essence:

  • Last summer, WHO created the Antimicrobial Resistance Multi-Partner Trust Fund (AMR-MPTF). Go here for the announcement.
  • The Trust Fund is a 5-year project (through 2024) that provides a vehicle for donations to support countries and the implementation of the Tripartite’s AMR workplans. Particular goals are providing technical support to countries designing National Action Plans on AMR and scaling up local action.
    • Context: the Tripartite is the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (OIE), and the World Health Organization (WHO).
  • The Netherlands kick-started the Trust Fund with $5m. There is a goal of raising $70m and it looks like the fund now has $7m after a donation by Sweden. Go here for a web page that shows funding — this web page also has some interesting text on Governance for the Fund.


So, now we have a call for a consultant to oversee the Fund. Here are key excerpts from the full posting:

  • “A consultant is required to support the operationalization of the AMR MPTF …   
  • “The Coordinator will manage the first round of country and global proposal development, approval and disbursement, …   
  • “The  Coordinator will be a member of the Tripartite Joint Secretariat …  
  • “He/she will be responsible for the coordination and day-to-day management of the Fund and will report to the WHO Tripartite Liaison officer, working closely with the Steering Committee, the Tripartite, and UNDP Multi-Partner Trust Fund Office (MPTF Office) as Administrative Agent.”


Wow! This sounds like a great role for the right person. Could this be you? If you are interested, your CV and motivational letter are due to bersets@who.int by 17 March 2020.

All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Operating Partner, Advent Life Sciences. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://amr.solutions/blog/


Full posting as received today by email
Contract type
: Consultancy
Application Deadline: 17th  March 2020
Contact: Stéphanie Berset
Email address: bersets@who.int
Consultancy Reference: AMR/GCP/2020/#4
 
Purpose of the Consultancy: Support the establishment of the Antimicrobial Resistance Multi-Partner Trust Fund (AMR-MPTF).
 
Background: The Department of Global Coordination and Partnership on Antimicrobial Resistance (GCP) leads and coordinates the global One Health response to antimicrobial resistance through facilitating and managing strategic and innovative partnerships and providing secretariat services to global governance mechanisms on antimicrobial resistance in collaboration with the FAO, OIE  and other UN and international agencies as well as Member States and partners including the civil society and private sector. The Department facilitates the implementation of the recommendations of the UN Interagency Coordination Group on Antimicrobial resistance, strengthen evidence-based and coordinated response against antimicrobial resistance across the One Health spectrum in humans, animals, plants, food, feed and the environment through the development and implementation of global vision, goals and targets, political advocacy and engagement, and facilitating innovative partnerships and contributes towards the achievement of the SDGs. It also promotes synergy, set priorities and advocate to unblock bottlenecks for research and development for antimicrobial resistance across the One Health spectrum.
                      
A consultant is required to support the operationalization of the AMR MPTF and ensure robust systems, practices, and ways of working are designed and clearly documented in the operational materials.   The Coordinator will manage the first round of country and global proposal development, approval and disbursement, and ensure that robust systems are built for collaboration between the three organisations and the management of funds and results. The  Coordinator will be a member of the Tripartite Joint Secretariat and will provide strategic, operational and administrative support to the Fund and its governance body, the AMR MPTF Steering Committee.  He/she will be responsible for the coordination and day-to-day management of the Fund and will report to the WHO Tripartite Liaison officer, working closely with the Steering Committee, the Tripartite, and UNDP Multi-Partner Trust Fund Office (MPTF Office) as Administrative Agent.
 
 
Work to be performed

  • Manages the AMR MPTF, including the development and oversight of work planning systems and processes
  • Establishes clear and transparent mechanisms to ensure prompt flow of funds. 
  • Develop systems to support the development of quality programming and results management of the Fund and project proposals, including facilitating linkages between the country teams and Tripartite substantive policy experts at regional and global level;
  • Organizes the calls for proposals and convenes the necessary technical expertise to appraise such proposals; 
  • Develops systems to monitor the implementation of approved projects with support from and participating partner entities;
  • Develops systems to Ensure the monitoring of operational risks and AMR MPTF performance; 
  • Drafts and implements fund monitoring and evaluation plan;
  • Leads the finalization of the operating manual 
  • Liaises with the Administrative Agent (MPTFO) on fund administration issues
  • Develop the template for annual narrative reports on Fund progress, in accordance with the agreed results framework and respective indicators, including on the activities of the Secretariat; 
  • Consolidates narrative reports and compiles country and Fund level baseline data for inclusion in the results framework, and facilitates annual progress reviews;
  • Provide ad hoc reporting on fund activities and progress when required.
  • Develops briefings to support directors in resource mobilization
  • Provides logistical and operational support to the AMR MPTF Steering Committee
  • Where necessary manage the virtual review of proposals by Steering Committee; 
  • Other duties as requested by the Joint Tripartite Secretariat and AMR MPTF Steering Committee.

 
   Deliverables

  1. Systems established to monitor fund flows, results and risks for AMR-MPTF.
  2. Support to the operationalization of the first round of MPTF proposals at global and country level.
  3. Finalization of operational manual
  4. Templates developed for reporting
  5. Briefings as required

 
Requirements for qualifications and experiences
Educational Qualifications:  Essential: Advanced university degree in international development, international relations, public administration, public policy, public health or other relevant social sciences is required.

WHO Competencies
o Communicating in a credible and effective way
o Producing results
       o Ensuring effective use of resources
       o Building and promoting partnerships across the organisation and beyond
o Moving forward in a changing environment
 
Experience required:
Essential: A minimum of 10 years’ experience in international development in a government, multilateral or civil society organization working in a multi-cultural setting, including at least two years outside one’s own country, is required.
 
Desirable:

  • Experience in fund management (managing Multi-Donor Trust Funds or large-scale multi-stakeholder programmes including results-based management, risk management, finance and operations) and resource mobilization, and knowledge of financing for development is required.
  • Understanding and experience in innovative financing, joint programming and partnerships, and country level joint UN work, will be significant assets.

 
Language requirements:
Essential: Fluency in English is required.
Desirable: Knowledge of other WHO official language would be an asset
 
Remuneration:
The remuneration will be based on a monthly fee which is in the range US$8000 – US$9400 depending on the selected consultant’s expertise and years of experience. This is an accordance with the WHO remuneration scales for international consultants. The final monthly fee will depend upon the selected consultant’s experience and expertise. Payments will be made following satisfactory completion of a set of deliverables. In line with WHO norms, payment will be made in instalments on satisfactory completion of a set of deliverables. A cost of living allowance of up to 3,000 CHF per month may also be available.
 
Place of assignment:
The place of assignment will be WHO Headquarters, Geneva, Switzerland
 
If you are interested to apply, please send your CV and motivational letter to bersets@who.int not later than 17 March 2020

Current funding opportunities:

  • Open now through 16 Mar 2020: CC4CARB, NIAID’s call for applications to fund an innovative Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). Go here for details.
  • Open now through 9 Apr 2020: NIAID Broad Agency Announcement (BAA) soliciting contract proposals for preclinical and clinical development of vaccines, therapeutic, and diagnostics for microbial pathogens. Go here for more.
  • Dates for the 2020 funding rounds for Novo REPAIR Impact Fund will be announced May 2020. Go here for current details.
  • 2020 funding rounds for CARB-X have not been announced.

Upcoming meetings of interest to the AMR community:

  • 5 Mar 2020 (FDA, White Oak Campus, 8.30a-5.00p EST): FDA workshop entitled “Advancing Animal Models for Antibacterial Drug Development.” FR notice is here and registration is here. The workshop will be webcast.
  • 12-13 Mar 2020 (Basel): BEAM-, Novo REPAIR-, CARB-X-, DZIF-, ND4BB-, ENABLE-supported (among a long list!) Conference on Novel Antimicrobials and AMR Diagnostics. Details are here, poster deadline is 12 Dec 2019.  
  • 16-17 Mar 2020 (London): BSAC Spring Conference entitled: “Bridging the gap between science, policy and effective antimicrobial use.” Go here for details. 
  • 20 Mar 2020 (Boston, MA): 7th annual BAARN (Boston Area Antimicrobial Resistance Network) Meeting. Chaired by Lawson Ung and Michael Gilmore, talks start at 9am and end with a reception at the Harvard Museum of Natural History. Go here to register; you can also contact Lawson Ung (lawson_ung@meei.harvard.edu) for other inquiries.
  • 26-30 Mar 2020 (Atlanta, GA): CDC- and SHEA-sponsored 6th International Conference on Healthcare Associated Infections. Go here for details.
  • 30 Mar 2020 (everywhere): Deadline for applications for the Molecular Mycology pathogenesis course at Marine Biological Laboratory, Woods Hole. Now in its 24th year, the hands-on residential course runs 17 July to 2 Aug and gets rave reviews. Go here for more.
  • 9 Apr 2020 (everywhere): Final date for applications for NIAID/DMID call (link) for AMR-related vaccines, therapeutics, and diagnostics.
  • 17 Apr 2020 (Paris): Pre-ECCMID workshop entitled “Machine Learning for Clinical Microbiology”. Go here for details. 
  • 18-21 Apr 2020 (Paris): Annual ECCMID meeting (#30)
  • 8 May 2020 (Silver Spring): FDA workshop entitled “Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection.” Go here to register.
  • 25-30 May 2020 (Rotterdam), Annual ESPID meeting (European Society for Pediatric ID, #38)
  • 18-22 Jun 2020 (Chicago), ASM Microbe 2020. Go here for details.
  • 27-28 Jun 2020 (Bryant University, Rhode Island): Drug Resistance Gordon Research Seminar entitled “Mechanisms and Approaches to Overcoming Drug Resistance in Cancer, Infectious Disease and Agriculture” for graduate students and postdoctoral scientists. Go here for details … this immediately precedes the GRC listed just next
  • 28 Jun-3 Jul 2020 (Bryant University, Rhode Island): Gordon Research Conference (GRC) entitled “Strategies to Disrupt Drug Resistance in Infectious Disease, Cancer and Agriculture.” Go here for details.
  • 2-7 Aug 2020 (Il Ciocco, Tuscany, Italy): Gordon Research Conference (GRC) on Antibacterial Discovery and Development: “Now is the time to re-boot antibiotic R&D before it’s too little, too late.” Go here for details.
  • September 2020. University of Sheffield (UK). Applications are being taken for a new 1-year (full-time) or 2-year (part-time) Masters of Science course in Antimicrobial Resistance. The program runs annually from September and covers microbiology, clinical practice and policy. The course webpage is here.
  • 1-4 Sep 2020 (Dublin): Annual ASM-ESCMID Conference on Antibiotic Development #5! Mark your calendar now and go here for details.
  • 9-10 Sep 2020 (Washington, DC): US PACCARB public meeting. Go here for details.
  • 22-25 Sep 2020 (Albuquerque, New Mexico): Biannual meeting of the MSGERC (Mycoses Study Group Education and Research Consortium). Save-the-date announcement is here, details to follow.
  • 17-25 Oct 2020 (Annecy, France): Interdisciplinary Course on Antibiotics and Resistance (ICARe). This is a soup-to-nuts residential course on antibiotics, antibiotic resistance, and antibiotic R&D. The course is very intense, very detailed, and gets rave reviews. The date is set for 2020 and the program will ultimately appear here. Registration is limited to 40 students and opens 15 Mar 2020.
  • 10-13 Apr 2021 (Vienna): Annual ECCMID meeting (#31)
  • 3-7 Jun 2021 (Anaheim), ASM Microbe 2021. Go here for details.

Dear All,
 
The IDWeek 2024 program committee is again seeking programs on novel antimicrobial agents and novel diagnostics for presentation in pipeline sessions! Here’s what is sought:

  • “Industry partners are invited to submit antimicrobials that are in preclinical stages of development (Phase II and III preferred) or recently approved after January 2024.
  • “The pipeline sessions will include antibacterials, antifungals, and antivirals (excluding COVID-19 and HIV).
  • “The committee also invites companies developing novel diagnostic technologies with a minimum of some preliminary proof of concept data to submit.” 

This is a great opportunity to tell the story of your development project! The deadline to submit is Wednesday, June 26 via the application portal. Any questions should be directed to program@idsociety.org. Please share this email with anyone you think might be interested in applying!
 
In addition, I’ll also note that those with a more general story to tell should look at the BugHub Stage (and the Global BugHub stage). Both BugHub variants seek “presentations that touch on your experience of working in infectious diseases and presentations that ultimately lead to a greater understanding of our diverse field” via a TED Talk-esque speech about your work. The deadline for applications is 26 June, the same as for the pipeline sessions.

I look forward to seeing you there! All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Operating Partner, Advent Life Sciences. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://amr.solutions/blog/. All opinions are my own.

John’s Top Recurring Meetings

Virtual meetings are easy to attend, but regular attendance at annual in-person events is the key to building your network and gaining deeper insight. My personal favorites for such in-person meetings are below. Of particular value for developers are the AMR Conference and the ASM-ESCMID conference. Hope to see you there!

  • 27-30 April 2024 (Barcelona, Spain): 34th ECCMID, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. Go here for details. 
  • 17-20 Sep 2024 (Porto, Portugal): ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. Go here for the meeting’s general website. You can’t register (yet) for the 2024 event, but save the date!
  • 16-20 Oct 2024 (Los Angeles, USA): IDWeek 2024, the annual meeting of the Infectious Diseases Society of America. Save the date! More details to come!
  • 25-26 February 2025 (Basel, Switzerland): The 9th AMR Conference 2025. Go here to register

Upcoming meetings of interest to the AMR community:

  • [NEW]  9 Apr 2024 (virtual, 830a-10a ET): GARDP’s next REVIVE webinar entitled “Progressing a discovery project – Criteria and challenges.” Register here.
  • [NEW] 9 Apr 2024 (virtual, 10a-1130a ET): CDC webinar “Impacts of Antimicrobial Resistance on Cancer Care.” Click here for details and to register.
  • 10-11 Apr 2024 (virtual): Sepsis Alliance AMR Conference, a 2-day conference focused on “Practical technologies to manage sepsis and counteract the expanding challenge of antimicrobial resistance.” Go here for details and to register.
  • 26 Apr 2024 (Barcelona, Spain): ESCMID workshop entitled “Using Data Science and Machine Learning for Infection Science: A Hands-on Introduction.” Click here to register or here for more details. 
  • 27-30 April 2024 (Barcelona, Spain): 34th ECCMID, the annual meeting of the European Society for Clinical Microbiology and Infectious Diseases. See Recurring Meetings list, above.
  • 26-31 May 2024 (Montreal, Canada): EDAR7, the McGill AMR Centre’s 7th edition of their Environmental Dimension of Antimicrobial Resistance conference. Go here for details; final abstract deadline is 21 Dec 2023.
  • 28-29 May 2024 (in person, Uppsala, Sweden): Uppsala Antibiotic Days, a broad-ranging 2-day program hosted by the Uppsala Antibiotic Center. Go here for details and to register.
  • [NEW] 30-31 May 2024 (face-to-face in Rockville, Maryland as well as online, 8.30-5.30p ET on 30 May, 9-2.40p on 31 May): NIAID-sponsored workshop entitled “Towards realizing the promise of adjunctive immune therapy for invasive fungal infections”. The agenda covers host immunity to invasive fungal infections, immune modulators in the context of fungal infections; and strategies for testing immune modulators as adjunctive therapy. Go here for more details and to register.
  • 9-13 June 2024 (in person, Ascona, Switzerland): “New Approaches to Combat Antibiotic-Resistant Bacteria, 2nd Edition” is a Sunday-Thursday residential workshop focused on the deep biology of AMR. Sponsored by NCCR AntiResist (a Swiss National Science Foundation consortium), the scientific program has the feel of a Gordon Conference. Space is limited, so you are encouraged to apply promptly — go here for details.
  • 13-17 June 2024 (Atlanta, Georgia): ASM Microbe, the annual meeting of the American Society for Microbiology. You can’t register yet, but you can go here for general details.
  • 17-20 Sep 2024 (Porto, Portugal): ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. See Recurring Meetings list, above.
  • 16-20 Oct 2024 (Los Angeles, USA): IDWeek 2024, the annual meeting of the Infectious Diseases Society of America. See Recurring Meetings list, above. 
  • 19-27 Oct 2024 (Annecy, France, residential in-person program): ICARe (Interdisciplinary Course on Antibiotics and Resistance). Now in its 8th year, Patrice Courvalin directs the program with the support of an all-star scientific committee and faculty. The resulting soup-to-nuts training covers all aspects of antimicrobials, is very intense, and routinely gets rave reviews! Seating is limited, so mark your calendars now if you are interested. Applications open in March 2024 — go here for more details.
  • 4-5 Dec 2024 (in person, Washington, DC): “Fungal Dx 2024: Fungal Diagnostics in Clinical Practice” is a 2-day in-person workshop organized by ISHAM‘s Fungal Diagnostics Working Group. The program and registration links are available at https://fungaldx.com/; the agenda is comprehensive and features an all-star global list of speakers.

Share

48,015 → 0: Antibacterial discovery is hard. Really, really hard.

Dear All (and with thanks to Patricia Bradford for co-authoring this newsletter), When you are seeking novelty, antibacterial discovery is hard … really, really, REALLY hard. And it gets even harder if you want activity vs. Gram-negative bacteria. As the latest proof of this, a paper from GARDP’s Blasco et al. describing use of an

Call for Pull: Swiss Roundtable on Antibiotics

Dear All, To end the week, we have a really lovely paper from the Swiss Roundtable on Antibiotics (a multidisciplinary, non-profit Swiss association). Here are the links you need: The new (25 March 2024) paper entitled “Effective antibiotics for the Swiss health care system: today and in the future.” A prior (7 Feb 2023) paper

Help PASTEUR cross the finish line: Action Alert from IDSA!

Dear All, Today’s news is that the House PASTEUR sponsors (Drew Ferguson [R-GA-3], Scott Peters [D-CA-50], Jake LaTurner [RKS-2] and Mike Levin [D-CA-49]) are urging House leadership to authorize the PASTEUR Act without initially having funding attached. Although this may seem counterintuitive, initial passage as a $0 bill is a solid strategy — it is common

Scroll to Top